Griseofulvin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 23.04.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antimycotic. out of trade in Germany!

Half-lifeThis section has been translated automatically.

22 h

Pharmacodynamics (Effect)This section has been translated automatically.

Fungistatic effect, inhibition of mitosis of dermatophytes. Incorporation into newly formed keratin of hair roots, nail matrix and epidermis (latency period 30 days).

IndicationThis section has been translated automatically.

Systemic in severe dermatophyte infections. Approved antimycotic against trichophyton and microsporum species in children. Topically used for the treatment of superficial dermatomycoses and for supportive therapy of Tinea unguium.

Dosage and method of useThis section has been translated automatically.

  • Cream: Apply 1-3 times/day to the affected skin areas.
  • Systemic: 0.5-1 g/day for 3 months p.o., children < 14 years: 10-20 mg/kg bw/day (equivalent to 1-3.5 tablets of a preparation containing 125 mg griseofulvin); treatment duration: 4-8 weeks. Take unchewed with a fatty meal with liquid.

Standard concentrationThis section has been translated automatically.

5% as cream.

Undesirable effectsThis section has been translated automatically.

  • Topical: Paragroup allergy.
  • Systemic: nervousness, gastrointestinal problems, headache, fatigue, xerostomia, blood count changes (leukopenia, neutropenia, monocytosis).

Notice! Under griseofulvin, check the blood count twice in the first month of treatment, later every 2-3 months. Due to potential teratogenicity, effective contraception should be used, whereby the effect of oral contraceptives is reduced. Men should not conceive children during treatment and up to 6 months afterwards! Hepatotoxicity!

InteractionsThis section has been translated automatically.

See Table 1.

ContraindicationThis section has been translated automatically.

Liver and kidney damage (e.g. acute hepatic porphyria), pregnancy, lactation, collagenosis, acute hepatic porphyria.

Notice! Caution in case of known penicillin allergy (griseofulvin is produced by Penicillium species).

PreparationsThis section has been translated automatically.

Likuden, Gricin cream, Griseo 125

LiteratureThis section has been translated automatically.

  1. Seebacher C et al (2006) Tinea capitis. J Dtsch Dermatol Ges 4: 1085-1091

TablesThis section has been translated automatically.

Significant interactions of griseofulvin

Anticoagulants, oral

Griseofulvin degradation ↑, anticoagulant effect ↓

Barbiturates

Griseofulvin-Wirkung↓

Contraceptives, oral

Contraception ↓

Phenytoin

Griseofulvin effect ↑

Authors

Last updated on: 23.04.2021